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Summary
Background: The proinflammatory cytokine tumor necrosis
factor-a (TNF-a) elicits cellular responses by signaling through
a receptor complex that includes the essential adaptor mole-
cule RIP. One important consequence of signaling is activation
of the transcription factor NF-kB, and failure to downregulate
TNF-induced NF-kB transcriptional activity results in chronic
inflammation and death. Internalization of the receptor
complex plays an important regulatory role in TNF signaling.
Results: We report that CARP-2, a RING domain-containing
ubiquitin protein ligase (E3), is a negative regulator of TNF-in-
duced NF-kB activation. By virtue of its phospholipid-binding
FYVE domain, CARP-2 localized to endocytic vesicles, where
it interacted with internalized TNF-receptor complex, resulting
in RIP ubiquitination and degradation. Knockdown of CARP-2
stabilized TNFR1-associated polyubiquitinated RIP levels
after TNF simulation and enhanced activation of NF-kB.
Conclusions:CARP-2 acts at the level of endocytic vesicles to
limit the intensity of TNF-induced NF-kB activation by the reg-
ulated elimination of a necessary signaling component within
the receptor complex.
Introduction
TNF-a is a multifunctional cytokine that elicits many biological
responses that are critical for cellular homeostasis [1, 2].
Deregulation of TNF signaling has been implicated in a variety
of pathological conditions such as cachexia, inflammation, os-
teoporosis, and rheumatoid arthritis. TNF orchestrates most of
its cellular functions, either cell survival and proliferation or
apoptosis, via TNF-receptor-1 (TNF-R1) [3, 4].
TNF-induced NF-kB activation is crucial for immune
responses. Binding of TNF triggers recruitment of many
*Correspondence: srinivsr@mail.nih.govcytosolic proteins to TNF-R1 including TNF-receptor-associ-
ated death domain protein (TRADD), receptor interacting pro-
tein (RIP), and TNF-receptor-associated factor 2 (TRAF-2) [5].
The assembly of this complex (also known as complex I) takes
place immediately after stimulation at the plasma membrane,
where posttranslational modifications (such as polyubiquitina-
tion of several complex-associated proteins) occur, resulting
in the activation of the IkB kinase (IKK) complex and, subse-
quently, NF-kB [6–9]. This receptor-associated complex
containing RIP internalizes within minutes of formation and
fuses with the trans-Golgi network to form multivesicular
endosomes, and this event is believed to be critical to attenu-
ate inflammatory responses [5, 10]. However, the underlying
mechanisms that regulate NF-kB signaling during endocytosis
of the activated TNF-receptor complexes remain unknown.
RIP, a death-domain-containing serine/threonine kinase, is
heavily ubiquitinated upon recruitment to early cell-surface
TNF-R1 complexes in TNF-stimulated cells. RIP is essential
for the TNF pathway because RIP-deficient Jurkat human T
lymphoma cells and mouse fibroblasts have no TNF-inducible
NF-kB response [11–13]. NEMO, the regulatory subunit of the
IKK complex, specifically recognizes K63-linked polyubiquiti-
nated chains on RIP, triggering activation of IKK and NF-kB
[6, 8, 14]. The domain structure of RIP is organized into three
distinct regions: a C-terminal death domain (DD), an intermedi-
ate domain (ID), and an N-terminal kinase domain (KD). The DD
mediates RIP recruitment to the early TNF-R1 complex, and
Lysine 377 in the ID is the site of K63-linked polyubiquitination,
probably mediated by TRAF-2 [6, 11, 14]. Both DD and ID are
essential for TNF-induced IKK and NF-kB activation. Although
no functional role for the RIP KD has been established, it is
thought to be dispensable for downstream NF-kB signaling
[12, 13].
Recent reports indicate that a number of peripheral (as
opposed to integral membrane) proteins that localize to spe-
cific organelles through lipid-protein and protein-protein inter-
actions target the internalized receptor complexes and
provide necessary spatial and temporal regulation for signal-
ing [15, 16]. Because internalized TNF-R1 complexes are
known to associate with endocytic membrane vesicles, we
hypothesized that proteins in these intracellular compart-
ments might affect TNF-induced NF-kB activation by targeting
signaling complexes. Here, we present evidence that CARP-2,
a phospholipid-binding domain-containing protein with ubiq-
uitin protein ligase activity, localizes to endocytic vesicles,
recruits to internalized early TNF-R1 complex, targets internal-
ized RIP for proteasome-mediated degradation, and limits
TNF-induced NF-kB activation.
Results
CARP-2 Is a Novel Regulator of TNF-Induced
NF-kB Activation
To identify proteins that regulate TNF signaling in the endo-
cytic pathway, we focused on proteins that associate with
the endosomal and Golgi membrane vesicles with which
fusion of internalized TNF-receptor complexes occurs. Be-
sides transmembrane proteins, proteins with a particular motif
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known to localize to these vesicles [17, 18]. Therefore, we
searched the NCBI gene bank for FYVE motif-containing
proteins. Interestingly, two of the 45 FYVE domain-containing
proteins found also contain RING domains, a sequence that
confers ubiquitin protein ligase activity to many molecules
[19, 20]. Reasoning that molecules containing such properties
might be especially well-suited to interact with and modify
components of early TNF-R1-associated proteins, we tested
their ability to affect TNF-induced NF-kB activation. One of
the molecules, CARP-2 (caspase-8 and -10-associated RING
protein-2) (Figure 1A), is known to bind and negatively regulate
DED caspases but has not been reported to regulate TNF sig-
naling [21]. CARP-2 (also known as Rififylin/SAKURA) belongs
to a minor subgroup of FYVE-domain containing proteins with
no conserved phosphoinositide-binding motif [22–24]. In spite
of the missing PI3P binding property of the FYVE motif, this
sequence has been shown in overexpression studies to target
the protein to endocytic membrane vesicles [23]. The RING
Figure 1. CARP-2 Negatively Regulates TNF-
Induced NF-kB Activation
(A) Schematic diagram shows the domain struc-
ture and position of conserved Histidine 333 in
the RING domain of CARP-2.
(B and C) CARP-2 inhibits TNF-induced IKK acti-
vation and IkBa degradation. Extracts of 293T
cells transfected with indicated plasmids and
treated with TNF for 5 min (B) or as indicated
(C) were subjected to in vitro IKK kinase assay
(B) or probed for expression of indicated proteins
(B and C).
(D and F) CARP-2 inhibits TNF-induced NF-kB re-
porter activity. Extracts of TNF-stimulated 293T
cells expressing reporter plasmids along with dif-
ferent amounts of FLAG-CARP-2 variants (D) or
shRNA constructs (F) were assayed for reporter
activities and probed for CARP-2. Error bars rep-
resent SEM.
(E) CARP-2 inhibits TNF-induced IL-6 production.
IL-6 secreted from mouse embryonic fibroblasts
(MEFs) expressing CARP-2 variants was mea-
sured by ELISA, and expression of CARP-2 and
b-actin in the extracts is shown. Error bars repre-
sent SEM.
(G and H) Knockdown of CARP-2 prolongs TNF-
induced IKK activation and IkBa degradation.
Extracts of TNF-treated 293T cells expressing
shRNA constructs were subjected to in vitro
IKK kinase assay (G) or probed for expression
of indicated proteins (G and H).
domain is also functional and exhibits
ubiquitin protein ligase (E3) activity
in vitro and ex vivo [21, 22].
To assess the effect of CARP-2 ex-
pression on TNF-induced NF-kB activa-
tion, we analyzed the endogenous IKK
activity and IkBa degradation (Figures
1B and 1C). As expected treatment
of vector-only-expressing cells with
TNF-a resulted in increased IKK activa-
tion (Figure 1B). Expression of CARP-2
wild-type decreased IKK activity both
at basal level and upon TNF stimulation.
A substitution of alanine for a histidine in
the RING domain (H333A) that abrogates
E3 activity failed to reduce IKK activity, suggesting that E3
activity is required for CARP-2 inhibitory function (Figure 1B).
Consistent with these results, expression of CARP-2 wild-
type (Figure 1C) that did not affect the level of IkBa in unstimu-
lated cells prevented its TNF-induced degradation. In contrast,
the RING mutant had shown no such effect (Figure 1C).
Additionally, NF-kB reporter assays were used to assess the
effect of increased CARP-2 expression on NF-kB activation.
CARP-2 reduced TNF-induced NF-kB reporter activity in a
dose-responsive fashion (Figure 1D). At high concentrations
the RING mutant also exhibited some inhibition, which may
result from the ability of the RING mutant to bind to target pro-
tein(s) and affect its (their) function in a subtle way. This down-
regulation of NF-kB activity by CARP-2 was observed in all cell
lines such as HT1080 (human fibrosarcoma), HeLa (human cer-
vical carcinoma), and C2C12 (mouse myoblast) tested (data
not shown). To investigate the effect of CARP-2 expression
on NF-kB-mediated cytokine production, we examined IL-6
secretion in response to TNF stimulation in mouse embryonic
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(A and B) CARP-2 localizes to endocytic membrane vesicles. Confocal images of HeLa cells immunostained with control or CARP-2 (Red) (A), or CARP-2
(Red) and Rab 5 (Green) antibodies (B). Scale bar is 10 mm. Areas of colocalization are shown by line intensity profile.
(C) CARP-2 is recruited to TNF-R1 receptosomes. Magnetic TNF-R1 fractions and postnuclear extracts (lysate) from HeLa cells were probed for indicated
proteins.
(D) Internalized TNF-R1 vesicles associate with CARP-2-positive vesicles. Confocal images of HeLa cells labeled with Biotin-TNF/FITC (Green)-conjugated
streptavidine and anti-CARP-2 (Red). Colocalization analyses were performed with Zeiss AIM software v3.2 to give the overlay image of colocalized pixels,
scatter plots, and Pearson’s coefficients. Ch3 is FITC (green) and Ch4 is CY3 (Red). Scale bar is 10 mm.fibroblasts that express CARP-2 variants. Treatment of vector-
only-expressing cells with TNF-a resulted in increased produc-
tion of IL-6, but cells that express wild-type CARP-2 produced
very little IL-6 (Figure 1E). In agreement with the requirement of
E3 activity for CARP-2 inhibitory function, MEFs that express
the RING mutant (H333A) exhibited increased IL-6 production
both at the basal levels and upon TNF stimulation (Figure 1E).
Therefore, in TNF-stimulated cells, CARP-2 inhibits activation
of NF-kB in a largely RING-dependent manner.
To investigate the physiologic function of endogenous
CARP-2, we designed small hairpin RNA (shRNA) specific for
two different regions of CARP-2. Transfection of the siRNA
hairpins in 293T cells resulted in a large reduction in the level
of endogenous CARP-2 protein (Figure 1F). Knockdown of en-
dogenous CARP-2 expression enhanced TNF-induced NF-kB
reporter activity by approximately two-fold (Figure 1F). Con-
sistent with this, knockdown of CARP-2 prolonged the IKK
activation to as late as 60 min (Figure 1G) and delayed the
recovery of IkBa (beginning at 30–45 min in control cells but
occurring at 60–90 min in shRNA-treated cells) (Figure 1H).The observed effects of shRNAs are specific because coex-
pression of shRNA-resistant CARP-2, but not wild-type, res-
cued TNF-induced NF-kB reporter activity (Figures S1A and
S1B available online). The increase in TNF signaling in cells
with reduced CARP-2 suggests that the physiological function
of this molecule is to limit the intensity or duration of signaling.
CARP-2 Localizes to Membrane Compartments
and Recruits to Vesicles Containing
Endocytosed TNF Receptor
Previous studies have shown that overexpressed mouse
CARP-2 associates with membrane compartments in the peri-
nuclear region that are positive for the endosomal markers
Rab5 and Rab11 [23]. Therefore, to determine if endogenous
CARP-2 constitutively associates with endocytic membrane
vesicles, we developed a monoclonal antibody that specifi-
cally recognizes CARP-2 (Figures S2A and S2B). Confocal
microscopic analysis of cells stained with this antibody
showed punctate staining for endogenous CARP-2, mostly in
the cytosol (Figure 2A). A subset of these cytosolic vesicles
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(Figure 2B). No significant colocalization between CARP-2
and either Golgi marker GM130 or the lysosomal marker
Lamp1 was observed (Figure S2C). Collectively these results
suggest that endogenous CARP-2 associates constitutively
with, albeit undefined, membrane vesicles that fuse with inter-
nalized TNF-receptor complex (see below) and are referred as
CARP-2-positive vesicles in this manuscript.
Given that internalized TNF-receptor complexes fuse with
endocytic vesicles to form multivesicular endosomes (also
known as TNF receptosomes), we examined whether these
isolated TNF receptosomes include CARP-2 [10, 25]. As ex-
pected all the receptosome preparations from both HeLa
and U937 cells contain TNF-R1 (Figure 2C and Figure S2D).
After 5 min of internalization, significant amounts of CARP-2
were found along with markers of other endocytic vesicles
such as Rab5 and Rab7. Of note, barely detectable in the
cell lysate, these proteins were considerably enriched in iso-
lated receptosomes. This indicates that either CARP-2 protein
is directly recruited to internalized receptor complex or that
CARP-2 vesicles, similar to Rab5- and Rab7-positive vesicles,
fuse with endocytosed TNF receptosomes. Although the re-
cruitment of CARP-2 occurred in as early as 5 min, Lamp-1
Figure 3. CARP-2 Functions at the Level of the
Early TNF-R1 Complex
(A) CARP-2 inhibits NF-kB activation induced by
early TNF-R1 complex components. Extracts
from 293T cells transfected with indicated con-
structs along with reporter plasmids were as-
sayed for reporter activities. The fold increase
in the activity relative to vector background is
shown in parenthesis. Expression of signaling
molecules and one representative set of CARP-2
is shown.
(B and C) CARP-2 downregulates, and lactacys-
tin rescues, RIP expression. Expression of exog-
enous proteins in the extracts of 293T cells trans-
fected with indicated constructs and treated with
proteasomal inhibitor lactacystin are shown.
(D) CARP-2 binds to endogenous RIP. Extracts
from 293T cells expressing FLAG-CARP-2 vari-
ants were immunoprecipitated with anti-FLAG
antibody and probed for indicated proteins.
(E) Endogenous CARP-2 binds and promotes en-
dogenous RIP degradation in TNF-stimulated
cells. CARP-2 from extracts of TNF-stimulated
HeLa cells was immunoprecipitated and probed
for RIP and CARP-2.
(F) Endogenous CARP-2 binds endogenous RIP
in TNF receptosomes. TNF receptosomes iso-
lated from MG-132-treated HeLa cells were sub-
jected to immunoprecipitation with anti-CARP-2
antibody coupled to magnetic MACS microbeads
or with anti-rabbit IgG magnetic microbeads. RIP
and CARP-2 in total receptosomes are shown.
(a lysosomal protein) is recruited around
30–60 min, suggesting that the associa-
tion of CARP-2 is an early event that
occurs much before the fusion of the in-
ternalized TNF-receptor with lysosomal
compartments.
Additionally, confocal microscopy
was used to investigate the association
between CARP-2 and endocytosed
TNF-receptor complex. The intracellular
trafficking of TNF-a/TNF-R1 was followed by first incubating
HeLa cells with biotin TNF-a/streptavidin FITC at a low temper-
ature and then by increasing the temperature to 37C. Confo-
cal analysis of these cells stained with anti-CARP-2 antibody
showed (30 min after internalization) significant colocalization
of the receptor with CARP-2 (Figure 2D). The colocalization
coefficient (Pearson’s coefficient) for TNF receptor after
30 min of internalization ranged from 0.314 to 0.956. Thus,
these results demonstrate that internalized TNF-R1 complex
indeed associates with CARP-2.
CARP-2 Promotes Endogenous RIP Degradation
in TNF-Stimulated Cells
The association of the internalized TNF-R complexes with
CARP-2 suggests that CARP-2 inhibits NF-kB activation in
TNF-stimulated cells possibly by targeting one or more com-
ponents of the early TNF-R1 complex. To test this possibility
CARP-2 was coexpressed with a number of gene products
found in the early TNF-R1 complex whose overexpression in
cells is known to activate NF-kB. Coexpression of CARP-2
substantially inhibited the NF-kB activation induced by all
the three proteins, and the RING mutant was only slightly in-
hibitory (Figure 3A). The NF-kB activity induced by IKKa was
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function. Therefore, CARP-2 likely inhibits NF-kB activation
at the level of the early-signaling complex.
Given that E3 activity of CARP-2 is essential for its function,
we asked if CARP-2 might affect the expression of the mole-
cules in complex I. RIP protein level was downregulated by
coexpression of CARP-2 (Figure 3B). The downregulation
was specific for RIP, as CARP-2 had no effect on the level of
expression of either TNF-R1, TRAF-2, or NEMO (another criti-
cal regulator of NF-kB activation) under the same experimental
conditions (Figure 3B). The function of CARP-2 appears to be
specific for TNF signaling, as coexpression of CARP-2 had no
effect on the expression of IRAK (interleukin-1 receptor-asso-
ciated kinase) a functional homolog of RIP in IL-1 signaling and
an essential modulator of IL-1-induced NF-kb activation
(Figure S3). The RING mutant did not affect RIP protein expres-
sion (Figure 3B), demonstrating that the protein ubiquitin
ligase activity of CARP-2 is critical for this effect. This was
strongly supported by the finding that the proteasome inhibi-
tor lactacystin reverses the loss of RIP protein in the presence
of CARP-2 (Figure 3C). In order to determine whether CARP-2
binds directly to RIP, immunoprecipitates of FLAG-tagged
CARP-2 from 293T cells were probed for endogenous proteins
with antibodies against TNF-R1, RIP, and TRAF-2 (Figure 3D).
Consistent with the specific downregulation of RIP protein,
immunoprecipitates from cell extracts expressing wild-type
CARP-2, but not vector, contained substantial amounts of
RIP protein and only a very little amount of TNF-R1 and
TRAF-2. Interestingly the RING-domain mutant, which was
unable to affect RIP expression or inhibit TNF signaling, also
coimmunoprecipitated these proteins equally well as wild-
type CARP-2, indicating that the RING-domain is dispensable
for RIP binding. These interactions were further confirmed as
extracts of cells expressing FLAG-tagged RIP and V5-tagged
CARP-2 contained RIP/CARP-2 complexes (Figure S4).
Because CARP-2 binds and downregulates RIP, we asked if
stimulation with TNF-a promotes interaction between these
proteins at an endogenous level. To answer this, endogenous
CARP-2 was immunoprecipitated from cells stimulated with
TNF-a in the presence or absence of MG-132, and the immuno-
precipitated material was probed with anti-RIP (Figure 3E).
Some interaction between RIP and CARP-2 was detected in un-
stimulated cells. But in stimulated cells we found no interaction
in the absence of MG-132 between CARP-2 and RIP. However,
whenproteasomaldegradation is inhibited,anti-CARP-2 immu-
noprecipitates RIP from cells stimulated by TNF-a for 30 min or
more, suggesting that after TNF stimulation CARP-2 binds and
rapidly degrades RIP (Figure 3E). In order to evaluate the direct
interaction of endogenous CARP-2 with endogenous RIP in
internalized TNF receptosomes, CARP-2 was immunoprecipi-
tated from TNF receptosomes isolated from MG-132-treated
HeLa cells after 0 and 30 min of internalization and probed for
CARP-2 and RIP (Figure 3F). TNF receptosomes in 30 min
contained both RIPand CARP-2, and RIP from lysed TNF recep-
tosomes was found to coimmunoprecipitate specifically with
CARP-2 antibody. These data demonstrate that CARP-2
directly interacts with RIP at internalized TNF receptosomes.
CARP-2 Targets the Internalized Receptor-Associated
RIP for Degradation
To test the hypothesis that RIP degradation at endocytic
vesicles is the mechanism to terminate NF-kB signaling, we in-
vestigated the effect of internalization on RIP degradation in
TNF-stimulated cells. Plasma membrane TNF-R1 is reportedto internalize through two distinct endocytic routes, namely,
clathrin-mediated endocytosis (CME) and raft/caveolar endo-
cytosis (RCE) [26–28]. Results from a previous study that
show reduced TNF-induced NF-kB target gene expression
upon inhibition of endocytosis indicate that active signaling
continues during TNF-receptor endocytosis [29]. Although
most cell types upon TNF stimulation exhibit rapid degrada-
tion of receptor-associated RIP, only NEMO-deficient cells
show significant decrease in total cellular RIP [8]. For this
reason, to investigate the effect of internalization on RIP ubiq-
uitination and degradation, we have also usedNEMO-deficient
cells in our studies.
As reported earlier, TNF stimulation significantly reduced
total cellular RIP in NEMO2/2 MEFs (Figure 4A). This decrease
in RIP level is not the result of apoptosis, as pan caspase inhib-
itor Z-VAD-FMK had failed to rescue the loss (Figure 4B).
Treatment with chlorpromazine (CPZ), a specific CME inhibi-
tor, effectively reduced the loss in a dose-dependent manner
(Figure 4A). Inhibition of TNF-R1 endocytosis by monodansyl
cadaverine (MDC) also prevented RIP loss (data not shown).
However, the presence of another inhibitor Filipin at a concen-
tration that specifically inhibits RCE, had very little effect,
suggesting that CME promotes the degradation of RIP in these
cells. Next, the effect of internalization on RIP ubiquitination
was assessed from cells treated with or without CPZ in the
presence of proteasome inhibitor MG-132, and stimulated
with TNF. In agreement with earlier published reports, protea-
somal inhibition efficiently blocked TNF-induced RIP loss
(Figure 4B). Although TNF stimulation in the presence of
MG-132 promoted RIP ubiquitination, the presence of CPZ
blocked RIP modification, suggesting that the observed loss
of RIP might be the consequence of internalization and subse-
quent ubiquitination (Figure 4C).
To investigate the role of CARP-2 in RIP degradation, we
transfected NEMO2/2 cells with shRNA specific for mouse
CARP-2. Although the knockdown of CARP-2 protein expres-
sion had minimal effect on RIP level in unstimulated cells, it par-
tially rescued the loss of RIP in stimulated cells (Figure 4D),
suggesting a possible role forCARP-2 in the degradation ofRIP.
This finding prompted us to examine whether inhibition of
RIP degradation with MG-132 results in accumulation of ubiq-
uitinated RIP at endocytic vesicles. To address this we purified
TNF-R1-associated endocytic vesicles from U937 cells treated
with or without MG-132 and analyzed the vesicles for RIP by
immunoblotting. MG-132 treatment did not alter the TNF-R1
complex fusion to endocytic vesicles (Figure 4E). Compared
to control (2MG-132) cells, inhibition of proteasomal degrada-
tion resulted in increased amounts of both polyubiquitinated
and unubiquitinated RIP (30 and 60 min samples). Not surpris-
ingly, the presence of MG-132 also stabilized TNF-R1 protein
(Figure 4E). Nevertheless, these results suggest that in TNF-
stimulated cells, internalized RIP ubiquitination and degrada-
tion broadly occur at endocytic vesicles. Although the initial
ubiquitination of RIP that occurs immediately after stimulation
at the plasma membrane (presumably mediated by TRAF-2)
promotes NF-kB activation, the later ubiquitination at endo-
cytic vesicles might be required for its degradation resulting
in termination of NF-kB activation. If CARP-2, indeed,
promotes RIP degradation, we reasoned that the knockdown
of CARP-2 expression should result in stabilization of this
receptor-associated RIP.
To test this, we immunoprecipitated TNF-R1 from HeLa cells
expressing CARP-2 shRNA and treated with TNF and immu-
noblotted for associated endogenous RIP. Consistent with
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found to coimmunoprecipitate with TNF-R1 from TNF-stimu-
lated cells (Figure 4F). Knockdown of CARP-2 resulted in a
substantial increase in receptor-associated RIP, both polyubiq-
uitinated and unubiquitinated, indicating that CARP-2 targets
RIP within the early TNF-R1 complex for degradation. Hence,
an increase in TNF-induced IKK/NF-kB activation in CARP-2
shRNA-expressing cells (Figures 1F–1H) could be the result
of stabilization of receptor-associated RIP.
CARP-2 Is a Ubiquitin Protein Ligase for RIP
Given that CARP-2 promotes RIP degradation, we investi-
gated whether CARP-2 functions as an E3 for RIP. We first
assessed the effect of CARP-2 on endogenous RIP ubiquitina-
tion in TNF-stimulated cells transfected with CARP-2 and
His-ubiquitin. Overexpression of CARP-2 itself caused some
ubiquitination of endogenous RIP, and this effect was
substantially increased upon TNF stimulation (Figure 5A,
left). Furthermore, in cotransfection experiments ,V5-CARP-2
wild-type, but not RING mutant, markedly enhanced the ubiq-
uitination of FLAG-RIP (Figure 5A, right). In these experiments
overexpression of FLAG-RIP alone resulted in moderate ubiq-
uitination. Because CARP-2 promotes RIP degradation via
ubiquitination, we hypothesized that CARP-2 modification of
RIP involves K48-linked ubiquitin chains. To test this we
cotransfected cells with CARP-2 variants along with HA-ubiq-
uitin mutants in which only K-48 or K-63 are available for poly-
merization and analyzed ubiquitination status of endogenous
RIP from TNF-stimulated cells. As expected, CARP-2 wild-
type markedly promoted the K48-linked ubiquitination of
RIP, and very little K63-linked RIP ubiquitination was observed
Figure 4. Endogenous CARP-2 Targets Internal-
ized Receptor-Associated RIP for Degradation
(A and B) Inhibitors of internalization and MG-132,
but not Z-VAD FMK, rescue TNF-induced RIP
degradation. Expression of endogenous RIP in
TNF-stimulated NEMO2/2 MEFs, pretreated with
medium or FILIPIN (2 mg/ml) or chlorpromazine
(CPZ) (1.6 mg/ml, 3.2 mg/ml, 6.4 mg/ml) (A) or with
indicated compounds (B), is shown.
(C) CPZ inhibits TNF-induced RIP ubiquitination.
RIP from extracts of TNF-stimulated NEMO2/2
MEFs pretreated with MG-132 and medium (UT)
or CPZ (10 mg/ml) was immunoprecipitated under
denaturing conditions and probed for ubiquitin
and RIP.
(D) Knockdown of CARP-2 rescues TNF-induced
RIP loss. Extracts of TNF-stimulated NEMO2/2
MEFs expressing shRNA constructs were probed
for indicated proteins.
(E) Ubiquitinated RIP accumulates on TNF-R1 en-
docytic vesicles in the presence of MG-132. Mag-
netic TNF-R1 fractions from U937 cells were
probed for indicated proteins.
(F) CARP-2 targets TNF-receptor-associated RIP
for degradation. Extracts from TNF-stimulated
HeLa cells expressing shRNA constructs were
precipitated with hamster anti TNF-R1 antibody
and probed for indicated proteins.
under these conditions (Figure 5B). In
agreement with this, expression of mu-
tant RIP that is unable to undergo K63-
linked polyubiquitination (K377F) was
reduced in RING-dependent manner by
CARP-2 (Figure S5). Additionally, the effect of CARP-2 variants
on the turnover of FLAG-RIP was assessed by pulse-chase
analysis. Consistent with its function as an E3 ligase, the deg-
radation of transfected FLAG-RIP was rapid in the presence
CARP-2 wild-type (Figure 5C). To determine if CARP-2 can
directly ubiquitinate RIP, in vitro ubiquitination assays were
performed by using methylated (blocked) ubiquitin. In the
presence of ATP, wild-type, but not the RING-domain mutant
of CARP-2, was found to ubiquitinate RIP protein (Figure 5D).
Taken together, the results demonstrate that CARP-2 binds
and ubiquitinates RIP, leading to its degradation.
RIP Kinase Domain Is Essential for CARP-2-Mediated
RIP Degradation
Earlier reports have shown that the RIP intermediate domain
and death domain are essential but the kinase domain is dis-
pensable for NF-kB activation [12, 13]. To determine which
portion of RIP interacts with CARP-2, we tested its binding
to individual regions of RIP. Because the different constructs
were not expressed in transiently transfected cells to the
same level, we expressed FLAG-tagged RIP constructs and
V5-tagged CARP-2 constructs individually in 293T cells and
used different amounts of the extracts from these cells for im-
munoprecipitation experiments. Interestingly the RIP kinase
domain, but not RIP lacking the KD, was found to specifically
coimmunoprecipitate with CARP-2 (Figure 6A), suggesting
a requirement of RIP KD for CARP-2-mediated RIP degrada-
tion. In order to test this possibility, we examined the effect
of CARP-2 on the degradation of RIP without KD in cotransfec-
tion and pulse-chase experiments. In agreement with its inabil-
ity to bind to RIP without its kinase domain, CARP-2 did not
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protein level (Figure 6B). Consistent with this, in pulse-chase
experiments the degradation of FLAG-RIPDKD remained
unchanged in the presence of wild-type or RING mutant
CARP-2 (Figure 6C). Thus, these results prove that the kinase
domain of RIP is essential for its binding and subsequent deg-
radation by CARP-2.
Given this apparent paradox regarding the role of the kinase
domain in NF-kB signaling, we hypothesized that this domain
might regulate the termination of NF-kB activation by targeting
internalized RIP to CARP-2 in intracellular compartments. In
such a scenario cells expressing only RIP without the kinase
domain should exhibit increased or prolonged NF-kB activa-
tion. In fact earlier it has been shown that expression of a con-
struct containing the ID-DD region of RIP in RIP-deficient
Jurkat cells has increased NF-kB activity as compared to
full-length RIP-expressing cells [13]. Indeed, TNF stimulation
of RIP2/2 MEFs expressing RIP lacking the kinase domain
are found consistently to have an increase in basal, as well
as TNF-inducible, NF-kB activity (Figure 6D). Thus, CARP-2
negatively regulates NF-kB signaling by binding to RIP of the
internalized early complex via the kinase domain leading to
RIP ubiquitination and degradation.
Discussion
Endocytic organelles are organized as a transport network
consisting of physically and biochemically distinct membra-
nous domains, which serve as intracellular stations that inte-
grate diverse signals to provide a high order of specificity
and regulation to signaling [16, 30–32]. The end result of a sig-
naling process is determined by factors, presumably associ-
ated with membrane vesicles that regulate the duration and
intensity of the signal. Although duration of signaling is an im-
portant parameter that ultimately determines the biological
outcome, to our knowledge, no factor(s) at the vesicles that
terminate TNF signaling have been reported.
In this report we propose that degradation of internalized
RIP by CARP-2 at endocytic vesicles dampens TNF-induced
IKK/NF-kB activation (Figure 7). Endocytosed TNF-receptor
complex that includes RIP is known to fuse with intracellular
compartments to form TNF receptosomes [10]. We now pres-
ent evidence that CARP-2 localizes to compartments that
associate with receptosomes and targets endocytosed RIP
for K-48-linked ubiquitination and proteosomal degradation.
Whereas results from pulse-chase experiments showed
marginal differences between wild-type and mutant CARP-2,
collective evidence from several experiments including
in vivo and in vitro ubiquitination assays proves that CARP-2
is an E3 for RIP. In knockdown experiments we observed
only small effects in RIP ubiquitination/IKK/NF-kB activation,
possibly owing to the presence of some residual protein in
our shRNA experiments and/or other molecules that could
functionally offset the effect of loss of CARP-2. A20 is a ubiqui-
tin-editing enzyme that negatively regulates TNF-induced
NF-kB activation by targeting, like CARP-2, TNFR1-associated
RIP for degradation [7]. Knockdown of either CARP-2 or A20
stabilized RIP in a similar manner (Figure S6A), and suppres-
sion of A20 expression together with CARP-2 further increased
RIP ubiquitination and slightly decreased the level of IkBa
compared to reduction of A20 alone (Figure S6B). These re-
sults indicate that CARP-2 might function cooperatively with
A20 in regulating TNF-induced NF-kB activation, with CARP-
2 acting at the endocytic compartments. Notwithstanding of
these similarities, the level of CARP-2, unlike A20 whose
expression is substantially upregulated by NF-kB, remained
unchanged upon TNF treatment (Figure S6C). More experi-
ments are needed to understand the relative contribution of
A20 and CARP-2 in the regulation of TNF signaling.
An unexpected outcome of our studies is the requirement of
the kinase domain of RIP for CARP-2 function. The dispens-
ability of the KD for TNF-induced NF-kB activation has long
been known [12, 13, 33]. Our data suggest, however, that the
kinase domain may have an inhibitory effect on RIP function.
Figure 5. CARP2 Is an E3 for RIP
(A) CARP-2 promotes TNF-induced endogenous
RIP ubiquitination. Purified His-ubiquitinated
proteins from TNF-stimulated 293T cells trans-
fected with indicated plasmids and treated with
MG-132 were analyzed with anti-RIP antibody
(left). 293T cells expressing pcDNA3-HA-ubiqui-
tin and pCMV-tag2B-RIP-His along with indi-
cated plasmids were pretreated with MG-132.
His-RIP was purified and analyzed for ubiquitina-
tion (right).
(B) CARP-2 mediates K48-linked polyubiquitina-
tion of endogenous RIP. Endogenous RIP from
TNF-stimulated 293T cells expressing indicated
plasmids, preincubated with MG-132, was immu-
noprecipitated under denaturing conditions and
probed for ubiquitin and RIP.
(C) CARP-2 promotes RIP degradation. 293T
cells transfected with pFLAG-CMV-RIP and
pcDNA3-nV5-CARP2 variants were incubated
with DMEM containing [35S] Pro-Mix for 30 min
and chased by growing in complete serum me-
dium. RIP from the extracts was immunoprecipi-
tated and analyzed by autoradiography and
PhosphorImager.
(D) In vitro ubiquitination of RIP by CARP-2. Mod-
ified RIP band is indicated.
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RIP2/2 MEFs expressing the RIP KD deletion mutant is in
agreement with earlier reports using RIP-deficient Jurkat cells
[13]. In principle it is possible that kinase activity might nega-
tively regulate TNF-induced NF-kB activity by affecting RIP/
CARP-2 interaction. Such a notion is supported by earlier
data that showed increased NF-kB transcriptional activity in
TNF-stimulated RIP-deficient cells expressing a kinase inac-
tive version of RIP (K45R or D138N) [13, 33].
Unlike other FYVE proteins that localize to Rab5- or EEA-1-
positive endosomes, endogenous CARP-2 mostly associates
with nonconventional endocytic vesicles. This could partly
be because of the differences in FYVE domains’ affinity to
phospholipids [24]. We speculate that the FYVE domain
restricts the function of CARP-2 to a specific set of endocytic
vesicles along the endocytic pathway of TNF signaling. Knowl-
edge of pathways such as this may have important implica-
tions in understanding the constitutive activation of NF-kB in
tumor cells.
Supplemental Data
Supplemental Experimental Procedures and six figures are available at
http://www.current-biology.com/cgi/content/full/18/9/641/DC1/.
Figure 6. CARP-2 Interacts with RIP Kinase Domain
(A) CARP-2 binds RIP kinase domain. Extracts from 293T cells expressing
FLAG-tagged RIP kinase domain (KD) or without kinase domain (DKD)
were incubated with extracts from cells expressing vector or wild-type
V5-CARP-2. RIP was immunoprecipitated and probed for CARP-2.
(B) Kinase domain is essential for CARP-2-mediated RIP loss. Extracts from
HeLa cells transfected with pcDNA3-nV5-RIP Full-length (FL) or DKD
together with CARP-2 were probed for indicated proteins.
(C) Kinase domain is essential for CARP-2-mediated RIP degradation. 293T
cells transfected with pcDNA3-nV5 -RIPDKD and pFLAG-CMV-CARP2
variants were analyzed by procedure described in Figure 5C.
(D) RIP kinase domain negatively regulates TNF-induced NF-kB activation.
Extracts of medium (Med) or TNF-treated RIP2/2 MEFs transfected with
indicated constructs in pMSCV vector along with reporter plasmids were
assayed for the reporter activities. Error bars represent SEM.Acknowledgments
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